Equities

Medikit Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7749:TYO

Medikit Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,988.00
  • Today's Change-5.00 / -0.17%
  • Shares traded4.00k
  • 1 Year change+14.92%
  • Beta0.2002
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

MEDIKIT CO., LTD. is a Japan-based company involved in the development, manufacture and sale of medical equipment. Its major products consist of artificial diagnostic equipment, which includes indwelling needles that are used for artificial dialysis purposes; indwelling venous needles (anesthesia type), which are used for blood and fluid transfusion purposes, and angiography equipment, which includes introducers and angiographic catheters.

  • Revenue in JPY (TTM)23.68bn
  • Net income in JPY3.09bn
  • Incorporated1984
  • Employees989.00
  • Location
    Medikit Co Ltd1-13-2, YushimaBUNKYO-KU 113-0034JapanJPN
  • Phone+81 338390201
  • Fax+81 338393977
  • Websitehttp://medikit.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7749:TYO since
announced
Transaction
value
Kobayashi & Co Ltd-Antileak BusinessDeal completed01 Apr 202501 Apr 2025Deal completed14.26%--
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Tissue Engineering Co., Ltd.2.26bn-461.45m24.73bn204.00--4.69--10.95-11.36-11.3655.62129.740.36614.015.6311,071,850.00-7.48-4.87-8.33-5.5159.6259.41-20.43-15.896.59--0.00---2.341.23-278.32--0.5717--
Kusurinomadoguchi Inc11.71bn2.59bn29.25bn484.0011.282.927.132.50228.38228.381,033.34882.360.6939--3.1924,186,230.0015.71--26.98--56.02--22.65------0.158--28.41--133.66------
Mizuho Medy Co Ltd11.26bn3.43bn34.18bn187.009.981.839.263.04179.80179.80591.12980.860.52251.552.09--15.9027.7417.9633.0669.4474.5130.4336.696.46-------1.4821.77-9.2262.0723.87--
Rion Co Ltd27.94bn2.98bn35.85bn1.01k12.011.088.231.28241.73241.732,267.252,682.200.71751.673.8927,692,170.007.656.578.727.6249.5350.1110.669.273.55--0.0028.398.365.377.829.9520.048.61
Nippon Care Supply Co., Ltd.34.10bn2.17bn39.31bn1.45k17.372.094.211.15139.36139.362,194.671,155.761.26101.8030.3523,453,350.008.007.3711.529.8036.4536.776.356.340.7615--0.091359.8011.9410.8813.573.7013.338.76
Cyberdyne Inc4.11bn-3.00m43.16bn211.00--1.6768.4010.51-0.0142-0.014219.46188.520.08331.607.7019,469,190.00-0.1034-1.36-0.1056-1.3861.0857.96-1.24-20.8013.94--0.0108--0.68919.5960.91---5.51--
Win-Partners Co Ltd87.25bn2.14bn43.38bn630.0018.751.7117.980.497275.8575.853,098.48830.261.8321.984.45138,488,200.004.494.298.527.9211.9812.402.452.591.62--0.0068.005.644.759.981.5233.839.52
France Bed Holdings Co Ltd61.19bn2.72bn46.42bn1.81k18.651.135.830.758771.6571.651,627.811,177.550.90172.946.0633,769,870.004.014.195.055.6555.0053.374.454.781.951,504.330.244146.932.382.93-6.0014.15-2.507.39
Japan Eyewear Holdings Co Ltd17.99bn4.22bn47.47bn580.0011.392.797.922.64172.64172.64736.69704.930.47411.8016.5631,022,410.0011.13--12.75--79.15--23.48--0.785318.060.4966--23.20--80.15------
Medikit Co Ltd23.68bn3.09bn47.53bn989.0014.120.95029.712.01211.98211.981,621.483,149.960.46433.144.1023,940,550.006.075.706.726.3038.5539.3713.0713.845.33--0.000241.813.222.54-1.820.854821.5712.47
Nagaileben Co Ltd16.69bn2.48bn55.23bn501.0022.291.4220.043.3180.6280.62544.001,263.590.38981.324.2033,321,640.005.786.906.137.4339.3743.3514.8418.6810.68--0.0067.123.48-0.097-8.81-5.8216.970.00
TAUNS Laboratories Inc14.92bn3.69bn55.44bn316.0015.343.1812.483.7133.9533.95139.96163.580.37210.91622.1347,226,430.009.20--13.12--64.90--24.72--0.948831.130.56--1.05--9.38------
Kitazato Corp10.98bn3.98bn62.08bn86.0015.583.2014.895.6599.6099.60274.45485.650.57231.838.92--20.77--21.73--66.93--36.29--14.33--0.00--2.20---4.63------
Shofu Inc38.97bn4.25bn64.60bn1.41k15.171.4111.921.66118.98118.981,092.321,279.850.75741.239.8127,577,490.008.287.279.278.2459.4558.4110.949.752.72--0.0032.9910.318.1918.1143.72-3.1930.39
Data as of Feb 17 2026. Currency figures normalised to Medikit Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

25.12%Per cent of shares held by top holders
HolderShares% Held
VARECS Partners Ltd.as of 28 Feb 20252.25m14.17%
Fidelity Management & Research Co. LLCas of 28 Feb 20251.03m6.48%
Polar Capital LLPas of 31 Dec 2025475.00k2.99%
Gesiuris Asset Management SGIIC SAas of 31 Dec 202589.90k0.57%
Lindsell Train Ltd.as of 30 Dec 202581.90k0.52%
HMG Finance SAas of 31 Dec 202540.22k0.25%
Dimensional Fund Advisors LPas of 31 Jan 202613.60k0.09%
Dimensional Fund Advisors Ltd.as of 30 Nov 20254.30k0.03%
Andbank Wealth Management SGIIC SAUas of 31 Dec 20253.79k0.02%
DFA Australia Ltd.as of 31 Dec 20252.19k0.01%
More ▼
Data from 30 Sep 2025 - 11 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.